Supplement Label Index

Compare with another brand → · RSS

Vianda

Vianda has 13 on-market SKUs in the DSLD, first entered 2018-04-25. 76.9% of its products declare at least one proprietary blend, and 35.0% of all its all-time SKUs are now off-market.

13
on-market SKUs
76.9%
with a blend
0.0%
gummies
35.0%
off-market churn

Report card

Compared with the median brand

Context for the numbers above: the same measures for the median of the 1,430 brands with at least 10 on-market products. A difference from the median is a description, not a grade; a specialty brand can sit far from the median for good reasons.

MeasureViandaMedian brand
Products with a proprietary blend76.9%26.7%
Products in an exact Formula Twins cluster7.7%10%
Products declaring a dose above an adult UL0%0%
Products listing a synthetic FD&C dye15.4%0%
Products listing titanium dioxide15.4%0%
Gummies0%0%
Products with a certification statement0%0%
Average excipients per product4.64.5
All-time SKUs now off-market35%15.4%

What it sells

  • Capsule: 9 (69.2%)
  • Tablet or Pill: 3 (23.1%)
  • Softgel Capsule: 1 (7.7%)

Compounds declared most often

Products (20)

ProductFormStatus
Altovis Capsule off-market
Avlimil Capsule off-market
Enzyte Capsule off-market
Enzyte E3 Triple Intensity Tablet or Pill off-market
Enzyte MRC Capsule off-market
Ogoplex Extract Pur Tablet or Pill off-market
Sorbera Capsule off-market
AliClear Capsule on-market
Altovis Capsule on-market
Avlimil Capsule on-market
Avlimil Multi Capsule on-market
Enzyte Capsule on-market
Enzyte E3 Triple Intensity Tablet or Pill on-market
Enzyte MRC Capsule on-market
Ogoplex Extract Pur Tablet or Pill on-market
Pavaxin Tablet or Pill on-market
Rudofil Capsule on-market
Sorbera Capsule on-market
Suvaril Capsule on-market
Vivora Softgel Capsule on-market